Table II.
P-value | |||||||
---|---|---|---|---|---|---|---|
Stage 1 | Stage 2 | Stage 3 | (1 vs. 2 vs. 3)b | (1 vs. 2)c | (1 vs. 3)c | (2 vs. 3)c | |
ADC (mm2/sec) | 0.289 (0.19-0.72) | 1.162 (0.73-1.28) | 0.867 (0.58-1.12) | 0.037a | 0.033a | 0.041a | 0.661 |
P-value | |||||||
Normal (N) marrow | Focal lesions (L) | Marrow infiltration (I) | (N vs. L vs. I)b | (N vs. L)c | (N vs. I)c | (L vs. I)c | |
ADC (mm2/sec) | 0.307 (0.26-0.42) | 1.010 (0.87-1.34) | 1.123 (0.85-1.13) | <0.001a | <0.001a | 0.001a | 0.585 |
aDifferences between groups are significant at P<0.05 threshold;
bKruskal-Wallis test;
cMann-Whitney U post-hoc test, adjusted P-value for pairwise comparison with Bonferroni correction. ADC, apparent diffusion coefficient; MRI, magnetic resonance imaging. ADC values are according to the type of bone infiltration. Data are expressed as median and interquartile (Q1-Q3).